Safety and feasibility of one-stage neonatal approach for short-segment Hirschsprung’s disease
PLOS One · 2026
DOI: 10.1371/journal.pone.0341212 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Quynh Anh Tran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The National Hospital of Pediatrics, Dong Da, Hanoi, Vietnam. Hauptthemen laut MEDLINE: Hirschsprung Disease, Laparoscopy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VinUniversity.
Abstract (Originalsprache)
Background
Early definitive surgery for Hirschsprung disease (HD) in neonates is increasingly adopted to reduce preoperative morbidity and preserve long term bowel function. However, comparative data across minimally invasive approaches in neonates with short segment disease remain limited. This study compared outcomes of single incision laparoscopic assisted endorectal pull through (SILEP), conventional laparoscopic assisted endorectal pull through (CLEP), and complete transanal endorectal pull through (TERPT) for rectosigmoid HD.
Methods
We conducted a retrospective cohort study of 55 neonates who underwent one stage definitive surgery before 28 days of age at a high volume center between January 2019 and December 2021. The primary outcome was long term bowel function assessed using the Rintala Bowel Function Score (BFS) after a minimum of 4 years of follow up. Secondary outcomes included operative parameters, postoperative complications (Clavien Dindo classification), and cosmetic outcomes using the Manchester Scar Scale (MSS) in the laparoscopic groups.
Results
All patients successfully underwent surgery at a mean age of 22.4 ± 4.3 days. Operative time differed across approaches and was shorter for SILEP (53.8 ± 11.9 minutes) and TERPT (52.1 ± 18.3 minutes) than for CLEP (70.2 ± 22.5 minutes, p = 0.036). At follow up (mean 54.0 ± 7.7 months), the overall BFS was 17.5 ± 2.5 with no significant differences among groups (p = 0.32). MSS was numerically lower for SILEP than for CLEP (6.2 ± 1.1 vs 6.8 ± 1.9, p = 0.53). Complications were infrequent, with 14 minor and 7 major events, and there was no mortality or Clavien Dindo grade IV or V morbidity.
Conclusion
SILEP, CLEP, and TERPT are feasible one stage options for neonates with rectosigmoid HD, with comparable long term bowel function and low rates of major complications. SILEP and TERPT were associated with shorter operative times, and SILEP showed a trend toward improved cosmetic scores compared with CLEP. These findings support an individualized approach to technique selection based on intraoperative requirements and institutional expertise.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, The National Hospital of Pediatrics, Dong Da, Hanoi, Vietnam.
- College of Health Sciences, VinUniversity, Gia Lam, Hanoi, Vietnam.
ORCID-Profile: Quang Thanh Nguyen
Förderung
- VinUniversity
Zitieren
APA
Tran, Q. A., Pham, H. D., Ly, D. B., Ngo, M. Q., Nguyen, N. T., Nguyen, L. T., & Nguyen, Q. T. (2026). Safety and feasibility of one-stage neonatal approach for short-segment Hirschsprung’s disease. PLOS One. https://doi.org/10.1371/journal.pone.0341212
Vancouver
Tran QA, Pham HD, Ly DB, Ngo MQ, Nguyen NT, Nguyen LT, et al. Safety and feasibility of one-stage neonatal approach for short-segment Hirschsprung’s disease. PLOS One. 2026. doi:10.1371/journal.pone.0341212
BibTeX
@article{Tran2026,
author = {Tran, Quynh Anh and Pham, Hien Duy and Ly, Dung Boi and Ngo, Minh Quang and Nguyen, Nhung Thi and Nguyen, Liem Thanh and Nguyen, Quang Thanh},
title = {Safety and feasibility of one-stage neonatal approach for short-segment Hirschsprung’s disease},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0341212}
}
EUVIMED